http://pharmtech.findpharma.com/pharmtech/Formulation/Article/list/40941 Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology. 2009-11-21T19:48:54Z http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40941&ref=25 Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete response letter; Watson appoints VP of global operations; more... 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Protect-Your-Scientific-Intellectual-Property-Proo/ArticleStandard/Article/detail/641752?contextCategoryId=40941&ref=25 As a pharmaceutical or biotechnology organization, your formulas, treatments and clinical findings are the "lifeblood" of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing ownership, revenue and consequently your business if you can't prove time-of-creation and authenticity. Learn how you can implement simple, cost-effective, and automated controls to protect your scientific intellectual property. 2009-11-13T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641752null REMOTE http://pharmtech.findpharma.com/pharmtech/Analytics/Choosing-the-best-construction-material-for-powder/ArticleStandard/Article/detail/641749?contextCategoryId=40941&ref=25 Selecting the best material of construction is a crucial part of the plant design process, the aim being to balance performance and cost to best advantage. For powder processors, choosing a material that eases flow can pay dividends throughout the lifetime of the plant, but there is limited data on which to base this decision. A recent study by Freeman Technology highlights the role of the FT4 universal powder tester for such studies and provides some valuable comparative data for a wide range of commercially available materials and finishes. 2009-11-13T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641749null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40941&ref=25 Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO; More... 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40941&ref=25 The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?contextCategoryId=40941&ref=25 In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639036null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40941&ref=25 Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its business team. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null HTML http://pharmtech.findpharma.com/pharmtech/Article/Moisture-Activated-Dry-GranulationmdashPart-I-A-Gu/ArticleStandard/Article/detail/639196?contextCategoryId=40941&ref=25 The authors explain a process for moisture-activated dry granulation in detail and provide guidance for the selection of excipients and equipment. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196/pt1109-fig-1-P64B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196null XML http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40941&ref=25 While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null XML http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40941&ref=25 FDA's Edwin Rivera-Martinez on dodging supply-chain challenges. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?contextCategoryId=40941&ref=25 Chronotherapeutic drug delivery systems (CRDDS) have been recognized as potentially beneficial to the chronotherapy (timeoptimized therapy) of widespread chronic diseases that display time-dependent symptoms. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638/Patel_small_thumbnail.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638null XML http://pharmtech.findpharma.com/pharmtech/Formulation/Current-Perspectives-on-Aseptic-Formulations/ArticleStandard/Article/detail/638763?contextCategoryId=40941&ref=25 The author details the factors in formulation design, requirements in facilites and equipment, and validation criteria for aseptic formualtions. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?contextCategoryId=40941&ref=25 The author describes how Merrion Pharmaceuticals reformulates parenteral drugs into tablets and capsules that are easier for patients to take and provide better bioavailability. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762null XML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40941&ref=25 Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business development, more... 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40941&ref=25 Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne Jones senior VP and chief information officer; more... 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40941&ref=25 Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more... 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40941&ref=25 Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more... 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null HTML http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40941&ref=25 AAPS President offers hope and solutions for the industry's challenging future. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null XML http://pharmtech.findpharma.com/pharmtech/Article/Formulation-and-Evaluation-of-Famotidine-Floating-/ArticleStandard/Article/detail/631709?contextCategoryId=40941&ref=25 The authors investigated the effects of formulation and processing parameters on floating matrix-controlled drug-delivery systems. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631709/60_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631709null XML http://pharmtech.findpharma.com/pharmtech/Article/Pharma-Capsules/ArticleStandard/Article/detail/631712?contextCategoryId=40941&ref=25 Brief pharmaceutical news items for October 2009. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631712null XML http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40941&ref=25 The nation's healtcare system needs an overhaul, but it has to be done right. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null XML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40941&ref=25 Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more... 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null HTML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Defining-the-ideal-properties-of-a-moisture-protec/ArticleStandard/Article/detail/629823?contextCategoryId=40941&ref=25 Applying a moisture protective barrier to tablet cores can help prevent degradation caused by ambient moisture. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629823/Cech_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629823null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-robust-formoterol-containing-suspension/ArticleStandard/Article/detail/629832?contextCategoryId=40941&ref=25 Formoterol presents formulators and manufacturers in the asthma and chronic obstructive pulmonary disease marketplace many challenges. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629832/Slowey_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629832null XML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40941&ref=25 Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more... 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628576null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40941&ref=25 Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more... 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626906null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Implementing-QbD-Powder-characterization-for-desig/ArticleStandard/Article/detail/625969?contextCategoryId=40941&ref=25 For those seeking to adopt a Quality by Design approach to pharmaceutical development and manufacture, effective definition of the 'design space' is a key activity. This paper considers the role of modern powder testers such as the FT4 from Freeman Technology, within this context. 2009-09-14T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/625969null REMOTE http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40941&ref=25 Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more... 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624922null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Controlled-Release-Formulations-a-Popular-Strategy/ArticleStandard/Article/detail/624970?contextCategoryId=40941&ref=25 Generic-drug companies are increasingly viewing the development of controlled-release formulations as a way of obtaining a competitive edge, according to a report published by Espicom Business Intelligence in late August 2009. 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624970null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40941&ref=25 Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more... 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623587null HTML http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40941&ref=25 As new process validation guidelines emerge, industry needs to reinvent how it releases product. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624651null XML http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40941&ref=25 After years of promomting QbD concepts, FDA's ready to take action on nonconformers. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624202null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-Incompatibility-probl/ArticleStandard/Article/detail/621300?contextCategoryId=40941&ref=25 Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621300/Dubey_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621300null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-influence-of-superdisintegrant-choice-on-the-r/ArticleStandard/Article/detail/621298?contextCategoryId=40941&ref=25 The addition of superdisintegrants to oral solid dosage forms can improve disintegration and, in turn, drug dissolution. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621298/Balasubramaniam_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621298null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Is-another-ODT-excipient-necessary/ArticleStandard/Article/detail/621306?contextCategoryId=40941&ref=25 Parteck ODT is a newly introduced ready-to-use excipient for fast melt tablets. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621306/Ohrem_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621306null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets-The-Effect-of-Recent/ArticleStandard/Article/detail/623097?contextCategoryId=40941&ref=25 The authors describe the various available technologies used in orally disintegrating tablets. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097/Supp_18_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-unstable-and-unpatent/ArticleStandard/Article/detail/621293?contextCategoryId=40941&ref=25 Combination products have been researched and administered for many years, some successfully and others not. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621293/Dubey_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621293null XML http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Tale-of-Two-Thermals/ArticleStandard/Article/detail/622361?contextCategoryId=40941&ref=25 Part one of the three?part core technology white paper series discusses the principle of operations of capillary thermal and immersible thermal gas mass flow measurement technologies. Taken together, these two methods cover a wide spectrum of gas mass flow measurements typically found in industrial applications. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/622361null REMOTE http://pharmtech.findpharma.com/pharmtech/Article/Moving-from-Vial-to-Prefilled-Syringe/ArticleStandard/Article/detail/623096?contextCategoryId=40941&ref=25 A Project Manager's Perspective. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623096/Supp12_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623096null XML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40941&ref=25 Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more... 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621551null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-Osmolality-and-pH-in-Bioreac/ArticleStandard/Article/detail/621669?contextCategoryId=40941&ref=25 Near-Infrared Spectroscopy (NIRS) can monitor a bioreactor in situ and in real time, so it is capable of replacing or supplementing osmolality and pH measurements off-line or current on-line pH methods. NIRS may be used to improve cell viability and productivity with closed-loop feedback. 2009-08-26T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621669null REMOTE http://pharmtech.findpharma.com/pharmtech/Analytics/NIR-Prediction-of-Solid-Dosage-Form-Dissolution-Pr/ArticleStandard/Article/detail/621674?contextCategoryId=40941&ref=25 It can be concluded from this study that Near-Infrared (NIR) prediction of dissolution profiles of intact tablets provides a fast and accurate means of non-destructively assessing tablets that is in step with the FDA Process Analytical Technology (PAT) initiatives. The data showed promising results that could relieve laboratory workload from dissolution testing. NIR was able to predict dissolution profiles for tablets with different levels of acetyltributyl citrate (ATBC) closely replicating the error of the lab method. 2009-08-26T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621674null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40941&ref=25 Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more... 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620144null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40941&ref=25 Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice; more... 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620139null HTML http://pharmtech.findpharma.com/pharmtech/Article/Is-FDAs-Draft-Process-Validation-Guidance-a-Mixed-/ArticleStandard/Article/detail/619188?contextCategoryId=40941&ref=25 The US Food and Drug Administration?s Draft Guidance for Industry?Process Validation: General Principles and Practices provides a life-cycle approach for validating pharmaceutical processes and aims to help pharmaceutical companies achieve consistently high product quality. 2009-08-19T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/619188null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Uncovering-the-root-cause-of-contamination-and-lev/ArticleStandard/Article/detail/619225?contextCategoryId=40941&ref=25 This article will share a detailed case study problem-solving example about a pharmaceutical manufacturer investigating a contaminant for a specific drug outcome. Step-by-step tutorial descriptions and graphics will illustrate how multivariate analysis can be used to determine the root cause of contaminated batches and ultimately solve the problem by accounting for batch genealogy. Examples are shared about how to use enabling technology, including: 1) Setting and reviewing specific parameters, such as the average pH and temperature of the fermentor. 2) Conducting comparisons of average flow rate, pressure and viscosity across contaminated batches. 3) Examining scatter plots to find correlations through regression analysis. 2009-08-14T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/619225null REMOTE http://pharmtech.findpharma.com/pharmtech/Formulation/FDA-Issues-Guidance-on-Monitoring-At-Risk-Melamine/ArticleStandard/Article/detail/618407?contextCategoryId=40941&ref=25 The US Food and Drug Administration released its Guidance for Industry titled Pharmaceutical Components at Risk for Melamine Contamination. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618407null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40941&ref=25 Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more... 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618405null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?contextCategoryId=40941&ref=25 Near-Infrared (NIR) technique for the determination of content uniformity of tablets provides a fast and accurate means of monitoring tablet production that is in step with the FDA Process Analytical Technology (PAT) initiatives. The FOSS XDS MasterLab™ was used to determine the content uniformity of tablets, instrument precision and accuracy. The data showed promising results that could relieve laboratory workload from HPLC analysis and bring analysis closer to "real-time" for process monitoring. 2009-08-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523511null REMOTE http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-CHO-Cell-Culture-Medium-Usin/ArticleStandard/Article/detail/523510?contextCategoryId=40941&ref=25 NIR spectroscopy using specialized transmission probes and fiber optics allows real-time in situ analysis of bioreactor feed stocks and product. With continuous NIR analysis, metabolic parameters and culture media constituents can be better monitored and controlled, which increases CHO cell life and lengthens the production phase. 2009-08-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523510null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40941&ref=25 Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific advisory board; more... 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616603null HTML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Formulation-and-Process-Optimization-of-Cinnarizin/ArticleStandard/Article/detail/615823?contextCategoryId=40941&ref=25 The authors prepared granules containing cinnarizine using polyethylene glycol 6000 as a melting binder and lactose monohydrate as hydrophilic filler. The effects of binder concentration and size were studied. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615823null XML http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40941&ref=25 Individuals and companies at the top seem to have no problem short-circuiting their success. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615813null XML http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40941&ref=25 Biotech firms must first close the gaps between science and biology on the path toward QbD. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615816null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pediatric-Formulations-Technical-and-Regulatory-Co/ArticleStandard/Article/detail/615617?contextCategoryId=40941&ref=25 Leading experts share their perspective on the specialized requirments when developing a pediatric formulation and examine dosage forms that can be used for this patient class in this roundtable moderated by Patricia Van Arnum. 2009-08-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615617/bottle_new_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615617/bottle_web_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Global-Outsourcing-A-Roundtable-of-Contract-Manufa/ArticleStandard/Article/detail/615507?contextCategoryId=40941&ref=25 Leading contract manufacturing organizations share their views on the current and future market dynamics shaping pharmaceutical outsourcing. 2009-08-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615507null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/European-Requirements-for-Pediatric-Formulations/ArticleStandard/Article/detail/615508?contextCategoryId=40941&ref=25 A summary of recent changes to European regulatory requirements for pediatric formulations. 2009-08-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615508/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615508null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Waivers-and-Deferrals-Under-the-Pediatric-Research/ArticleStandard/Article/detail/615511?contextCategoryId=40941&ref=25 The authors explain waivers and deferrals for pediatric studies of drugs and biologics as provided by the Pediatric Research Equity Act of 2007. 2009-08-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615511/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615511null XML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40941&ref=25 Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases final rule on authorized generic drugs and NDA submissions; more... 2009-07-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614815null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/Computer-Model-May-Help-Prevent-Antibody-Aggregati/ArticleStandard/Article/detail/614820?contextCategoryId=40941&ref=25 Researchers working on extending the shelf life of antibody drugs may find help in a computer model developed by a research team at MIT (Cambridge, MA). 2009-07-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614820null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40941&ref=25 Also, Gilead and Tibotec form agreement; FDA approves 2009-2010 flu vaccine; Catalent appoints VP in packaging unit; more... 2009-07-23T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612961null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Topical-Dermatological-Formulation-Development-nda/ArticleStandard/Article/detail/612809?contextCategoryId=40941&ref=25 "Things You Should Know" will answer many of your questions and will provide insight into issues you may not have considered — but should be aware when developing a topical formulation. The target product profile, dosage form selection, reasons for multiple excipients, the formulation development process, prototype screening, and lead formulation selection are discussed. 2009-07-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612809null REMOTE http://pharmtech.findpharma.com/pharmtech/Whitepapers/Better-Wet-Granulation-Development-Scale-Up-and-Ma/ArticleStandard/Article/detail/610802?contextCategoryId=40941&ref=25 Wet granulation is a common unit operation in the pharmaceutical industry, yet accurate endpoint detection remains a challenge. The author examines the contribution that dynamic powder rheometry can make, highlighting its ability to detect the transition from wet mass to granulate with the required sensitivity. Quantification of this transition point, with a measure that is independent of process scale, accelerates development and scale-up and improves manufacture. 2009-07-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/610802null REMOTE http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Seeks-Comments-on-Four-Excipient-Monographs/ArticleStandard/Article/detail/609488?contextCategoryId=40941&ref=25 The US Pharmacopeia is revising its monographs for four pharmaceutical excipients: propylene glycol, sorbitol solution, sorbitol sorbitan solution, and noncrystalllizing sorbitol solution. 2009-07-09T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609488null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40941&ref=25 Also, Lundbeck acquired LifeHealth; FDA is seeking a director of its new tobacco regulation branch; Charles River Labs announces personnel changes; more... 2009-07-09T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609491null HTML http://pharmtech.findpharma.com/pharmtech/Article/Advances-in-the-Pharmaceutical-Sciences/ArticleStandard/Article/detail/608519?contextCategoryId=40941&ref=25 As the pharmaceutical industry turns its efforts to biologic-based drugs and to more targeted delivery approaches, new tools are needed. Some recent developments are discussed. 2009-07-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608519null HTML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Stabilization-of-Interferon-alpha-2b-in-a-Topical-/ArticleStandard/Article/detail/608699?contextCategoryId=40941&ref=25 The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608699/Helix_rotate_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Modification-and-Characterization-of-Gellan-Gum/ArticleStandard/Article/detail/607459?contextCategoryId=40941&ref=25 The authors modified gellan gum using microwave technology and showed it can be used as an excipient in tablet formulations. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607459null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Novel-Approaches-for-Oral-Insulin-Delivery/ArticleStandard/Article/detail/609407?contextCategoryId=40941&ref=25 The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609407/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609407null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Less-Is-More-for-Low-Dose-Drugs/ArticleStandard/Article/detail/607458?contextCategoryId=40941&ref=25 Developers of low-dose drugs in solid oral dosage forms will find theoretical considerations and practical advice in a new book. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607458/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607458null XML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40941&ref=25 Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent appoints VP of quality and regulatory affairs; more... 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null HTML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Down-the-Track-Different-Speeds-with-Multiple-APIs/ArticleStandard/Article/detail/607448?contextCategoryId=40941&ref=25 Formulators and manufacturers have many options for modifying release profiles in multiple-API products. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607448/CoverStory_rotate_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Traditional-Chinese-Medicines-and-Western-Regulato/ArticleStandard/Article/detail/607454?contextCategoryId=40941&ref=25 Traditional Chinese Medicine is widely used, but questions persist regarding its regulatory status. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607454null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/A-Tale-of-Two-Techniques/ArticleStandard/Article/detail/607461?contextCategoryId=40941&ref=25 Pan coating has been the preferred method of coating tablets for more than 20 years, but core coating is becoming more popular. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607461/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607461null XML http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40941&ref=25 Is it good policy to pay for bad behavior? 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607467null XML http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40941&ref=25 The regulators are doing it. But industry's fear of sharing information may leave them behind. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607463null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Dynamic-avalanching-accurately-assesses-flowabilit/ArticleStandard/Article/detail/607093?contextCategoryId=40941&ref=25 Cefaclor is a β-lactam cephalosporin antibiotic that has a wide particle size distribution. Because of the nonporous nature of the material, the specific surface area value accounts for a significant amount of fine particles possibly present in the samples under analysis. 2009-07-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/272009/607093/Bonfichi_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?contextCategoryId=40941&ref=25 For pharmaceutical manufacturing companies, every decision in the product development process can impact the project outcome. By working closely with a reliable Contract Research Organization, clients can take the necessary precautions to avoid risks throughout the development program. A new white paper from SP Formulations, titled "Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes", presents some of the problems associated with 'simple' formulation changes. In addition to providing guidance on outsourcing drug development needs, the white paper presents a case study detailing the alternative approaches available for formulating a lyophilized product. 2009-06-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607230null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40941&ref=25 Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps down; more... 2009-06-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40941&ref=25 Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI makes changes to its India management team; more... 2009-06-18T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/603740?contextCategoryId=40941&ref=25 To address the increasing popularity of drug-injector systems, the US Food and Drug Administration last week released a Draft Guidance for Industry titled, Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products. 2009-06-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/603740null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40941&ref=25 Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more... 2009-06-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null HTML http://pharmtech.findpharma.com/pharmtech/News/European-Commission-Wont-Pursue-Directive-for-Exci/ArticleStandard/Article/detail/602697?contextCategoryId=40941&ref=25 The European Commission's (EC) Directorate-General for Enterprise and Industry (EC-DG Enterprise) announced last week that it will not continue preparing a commission directive on good manufacturing practices (GMPs) for certain excipients. 2009-06-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602697null HTML http://pharmtech.findpharma.com/pharmtech/News/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/602698?contextCategoryId=40941&ref=25 To address the increasing popularity of drug-injector systems, the US Food and Drug Administration last week released a Draft Guidance for Industry titled, Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products. 2009-06-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602698null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40941&ref=25 Also, WACKER expands Iowa facility; EMEA releases a Q&A document for PIPs; Metrics consolidates quality operations; more... 2009-06-04T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Outsourcing-Clinical-Trial-Materials/ArticleStandard/Article/detail/600809?contextCategoryId=40941&ref=25 CROs and CMOs expand to gain a piece of the market for clinical trial materials. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600809/rotate_ingredients_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?contextCategoryId=40941&ref=25 The authors describe the importance of a rapid and an abbreviated screening strategy in initial solvent screening. This article contains bonus online-exclusive material. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168null XML http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40941&ref=25 It can take a lot of work to make sure nothing happens. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Mapping-Opportunities-for-Patent-Positions/ArticleStandard/Article/detail/600805?contextCategoryId=40941&ref=25 Follow-on biologics could unleash the potential of several industries and may even spark economic recovery. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600805null XML http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40941&ref=25 Misleading the public about their investments—be it money or medicine—is unacceptable. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null XML http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?contextCategoryId=40941&ref=25 Pharmacosomes can pass through biomembranes efficiently and possess several advantages over traditional vesicular drug-delivery systems. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601891null XML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40941&ref=25 Also, Johnson & Johnson acquires Cougar Biotechnology; NIH launches program for rare and neglected diseases; PPD restructures leadership positions; more... 2009-05-28T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Tablet-Pro/ArticleStandard/Article/detail/517506?contextCategoryId=40941&ref=25 Tablet Pro defines Tablet Compression in detail and its relationship to each of the manufacturing steps in preparing the formulation for compress, proper compression operations and the essence of making quality tablets. 2009-05-28T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202008/517506null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40941&ref=25 Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO; more... 2009-05-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599148null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40941&ref=25 Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president and CEO; more... 2009-05-14T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598063null HTML http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/How-to-Make-a-Swine-Flu-Vaccine/ArticleStandard/Article/detail/597284?contextCategoryId=40941&ref=25 Covance talks about the risks, challenges, and tests required to develop a pandemic vaccine. 2009-05-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597284/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597284null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40941&ref=25 Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for botulinum toxin producs; C. Richter King joins IAVI; more... 2009-05-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597076null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Ethyl-Lactate-as-a-Pharmaceutical-Grade-Excipient-/ArticleStandard/Article/detail/596052?contextCategoryId=40941&ref=25 The authors investigate whether the addition of an antioxidant could be used to stabilize the solvent ethyl lactate by preventing the formation of peroxides 2009-05-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596052null XML http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40941&ref=25 The president of BIO proposes the ingredients needed for industry growth. 2009-05-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596053null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/596429?contextCategoryId=40941&ref=25 The authors describe the importance of a rapid and an abbreviated screening strategy by initial solvent screening in 20-mL scintillation vials. 2009-05-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/596429null XML